| Literature DB >> 19657451 |
K Nagendra Prasad1, Jing Hao, Chun Yi, Dandan Zhang, Shengxiang Qiu, Yueming Jiang, Mingwei Zhang, Feng Chen.
Abstract
Antioxidant activities of wampee peel extracts using five different solvents (ethanol, hexane, ethyl acetate, butanol and water) were determined by using in-vitro antioxidant models including total antioxidant capability, 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical scavenging activity, reducing power, and superoxide scavenging activity. Ethyl acetate fraction (EAF) exhibited the highest antioxidant activity compared to other fractions, even higher than synthetic antioxidant butylated hydroxyl toluene (BHT). In addition, the EAF exhibited strong anticancer activities against human gastric carcinoma (SGC-7901), human hepatocellular liver carcinoma (HepG-2) and human lung adenocarcinoma (A-549) cancer cell lines, higher than cisplatin, a conventional anticancer drug. The total phenolic content of wampee fraction was positively correlated with the antioxidant activity. This is the first report on the antioxidant and anticancer activities of the wampee peel extract. Thus, wampee peel can be used potentially as a readily accessible source of natural antioxidants and a possible pharmaceutical supplement.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19657451 PMCID: PMC2719755 DOI: 10.1155/2009/612805
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Comparative analysis of extraction yield and total phenolic content of wampee peel fractions obtained using different solvents.
| Fraction | Extraction yield (%)* | Total phenolic content ( |
|---|---|---|
| CF | 58.5 ± 0.09(a) | 46.2 ± 2.7(c) |
| HF | 6.86 ± 1.1(d) | 7.9 ± 0.4(e) |
| EAF | 9.21 ± 0.4(c) | 330 ± 9.9(a) |
| BF | 55.16 ± 2.5(a) | 30.3 ± 5.4(d) |
| WF | 18.21 ± 0.8(b) | 54 ± 6(b) |
*Values are mean ± standard deviation of three replicate analyses. CF, Crude ethanol fraction; HF, Hexane fraction; EAF, Ethyl acetate fraction; BF, Butanol fraction; WF, Water fraction. For each treatment, the means in a column followed by different letters were significantly different at P < .05.
Figure 1DPPH radical scavenging activity of the crude ethanol fraction (EF), hexane fraction (HF), ethyl acetate fraction (EAF), butanol fraction (BF) and water fraction (WF) from wampee peel.
Figure 2Total antioxidant capacity of the crude ethanol fraction (EF), hexane fraction (HF), ethyl acetate fraction (EAF), butanol fraction (BF) and water fraction (WF) from wampee peel. Higher absorbance value indicates higher antioxidant activity.
Figure 3Superoxide scavenging activity of the crude ethanol fraction (EF), hexane fraction (HF), ethyl acetate fraction (EAF), butanol fraction (BF) and water fraction (WF) from wampee peel.
Figure 4Reducing power activity of the crude ethanol fraction (EF), hexane fraction (HF), ethyl acetate fraction (EAF), butanol fraction (BF) and water fraction (WF) from wampee peel. Higher absorbance value indicates higher antioxidant activity.
Anticancer activities of the ethyl acetate fraction of wampee fruit pericarp and cisplatin.
| Cell line | % Anticancer activity* | ||
|---|---|---|---|
| Samples | Concentration ( | ||
| 50 | 100 | ||
| SGC-7901 | EAF | 75.8 ± 1.6 | 78.0 ± 1.7 |
| Cisplatin | 34.2 ± 2.2 | 63.9 ± 2.1 | |
| HepG-2 | EAF | 72.4 ± .65 | 77.8 ± 0.37 |
| Cisplatin | 33.2 ± 1.2 | 55.37 ± 2.2 | |
| A-549 | EAF | 69.2 ± 2.1 | 73.6 ± 0.75 |
| Cisplatin | 29.97 ± 3 | 49.5 ± 1 | |
*Values were the means ± standard deviations of three replicate analyses. SGC-7901 (human gastric carcinoma); HepG-2 (human hepatocellular liver carcinoma); A-549 (human lung adenocarcinoma); EAF, Ethyl acetate fraction of wampee; Cisplatin, positive control.